Showing results (501-510 of 520) with videos related to

Sort By:
Pageof 52
European Journal of Heart Failure|August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trialMarkus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Molecular Metabolism|February 25, 2016
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexiaMichaela Schäfer, Christian U Oeing, Maria Rohm, et al.
The Lancet. Infectious Diseases|December 3, 2014
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trialJoost H C M Kreijtz, Marco Goeijenbier, Fleur M Moesker, et al.
Nature Communications|December 1, 2025
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesisWentao Gui, Petr Paral, Bhavuk Dhamija, et al.
Circulation|December 9, 2016
Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart FailureIssam H Abu-Taha, Jordi Heijman, Hans-Jörg Hippe, et al.
Nature Metabolism|November 20, 2019
The lipid droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4Zegeye H Jebessa, Kumar D Shanmukha, Matthias Dewenter, et al.
Basic Research in Cardiology|February 25, 2021
Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytesPatrick Lugenbiel, Katharina Govorov, Pascal Syren, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2023
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancerMarkus S Anker, Alessia Lena, Eric J Roeland, et al.
Pageof 52